Multibagger small-cap stock RPG Life Sciences jumps 12% on 800% surge in Q4 PAT, healthy dividend. Details here
The company, post-market trading hours on Monday, posted its March 2025 quarter earnings, wherein it reported a 786% jump in profit after tax (PAT) to ₹ 117.35 crore, compared with ₹ 13.24 crore posted in the same quarter last year.
Even on a sequential basis, Q4 PAT was 236% higher than ₹ 34.93 crore posted in the December 2024 quarter.
Meanwhile, the company's revenue from operations jumped 12.67% year-on-year (YoY) to ₹ 143.09 crore in Q4 FY25, as against ₹ 126.99 crore in Q4 FY24. However, on a quarter-on-quarter (QoQ) basis, the figure declined by 17% from ₹ 172.71 crore posted in the third quarter of FY25.
At the end of the March 2025 quarter, Harsh Goenka owned 26,915 shares or a 0.16% stake in the company and was classified as a promoter.
The multibagger stock also recommended a solid dividend payout for its shareholders to the tune of ₹ 24 apiece.
RPG Life Sciences Baord recommended a final dividend of ₹ 20 per equity share (250% on the face value of ₹ 8 each) and additionally a special dividend of ₹ 4 per equity share (50% on the face value of ₹ 8 each) on account of significant exceptional profit on assignment of land for the financial year 2024-25, subject to the approval of shareholders at the ensuing Annual General Meeting, the company said in an exchange filing on Monday.
According to Trendlyne data, RPG Life Sciences has declared an equity dividend amounting to ₹ 16 per share in the past 12 months, resulting in a dividend yield of 0.72% based on the current market price.
Following the earnings announcement, the multibagger small-cap stock jumped 12% to hit the day's high of ₹ 2366.60 apiece, as against its closing price of ₹ 2108.80.
The company, which has a market capitalisation of ₹ 3,660 crore, has delivered solid returns to the investors, with the scrip up 41.24% in the last one year and 163% in the past two years. On longer time frames of five years and 10 years, RPG Life Sciences stock has rallied 766% and 1470%, respectively.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
OpenAI staff looking to sell $6 billion in stock to SoftBank, others: Source
Academy Empower your mind, elevate your skills Current and former employees of OpenAI are looking to sell nearly $6 billion worth of the ChatGPT maker's shares to investors, including SoftBank Group and Thrive Capital , a source familiar with the matter told Reuters on potential deal would value the company at $500 billion, up from $300 billion currently, underscoring both OpenAI's rapid gains in users and revenue, as well as the intense competition among artificial intelligence firms for Thrive and Dragoneer Investment Group did not immediately respond to requests for comment. All three investment firms are existing OpenAI News, which had earlier reported the development, said discussions are in early stages and the size of the sale could secondary share sale investment adds to SoftBank's role in leading OpenAI's $40 billion primary funding by its flagship product ChatGPT, OpenAI doubled its revenue in the first seven months of the year, reaching an annualized run rate of $12 billion, and is on track to reach $20 billion by the end of the year, Reuters reported earlier in August. Microsoft-backed OpenAI has about 700 million weekly active users for its ChatGPT products, a surge from about 400 million in February.
The Hindu
13 hours ago
- The Hindu
OpenAI staff looking to sell $6 billion in stock to SoftBank, others, source says
Current and former employees of OpenAI are looking to sell nearly $6 billion worth of the ChatGPT maker's shares to investors including SoftBank Group and Thrive Capital, a source familiar with the matter told Reuters on Friday. The potential deal would value the company at $500 billion, up from $300 billion currently, underscoring both OpenAI's rapid gains in users and revenue, as well as the intense competition among artificial intelligence firms for talent. SoftBank, Thrive and Dragoneer Investment Group did not immediately respond to requests for comment. All three investment firms are existing OpenAI investors. Bloomberg News, which had earlier reported the development, said discussions are in early stages and the size of the sale could change. The secondary share sale investment adds to SoftBank's role in leading OpenAI's $40 billion primary funding round. Bolstered by its flagship product ChatGPT, OpenAI doubled its revenue in the first seven months of the year, reaching an annualized run rate of $12 billion, and is on track to reach $20 billion by the end of the year, Reuters reported earlier in August. Microsoft-backed OpenAI has about 700 million weekly active users for its ChatGPT products, a surge from about 400 million in February.
News18
a day ago
- News18
India's GenAI Startups Boom: 3.7X Growth, $990M Funding In H1 CY2025: Report
India's Generative AI startup landscape has grown 3.7x to 890+ startups in the last 12 months, with GenAI Application startups reaching 740+. News18 India Generative AI startup landscape has witnessed an exponential rise with the cumulative number of startups growing 3.7x to 890+ in the last 12 months, according to NASSCOM report titled India ' Generative AI Startup Landscape 2025′. Moreover, GenAI Application startups grew 4x to reach 740+ (83% share) during the same period as compared to Services and Model/Infra segments, it added. Indian GenAI startups' cumulative funding grows by 30% YoY to reach $ 990 Million in H1 CY2025 as compared, significantly lower than global peers indicating constrained funding scenario in India, the NASSCOM report added. Early-stage funding remains the ecosystem's life force as late-stage capital vanishes. This shift indicates a strategic recalibration by VCs, who are now prioritizing demonstrable progress and near-term viability. The report said that the government's multifaceted approach marked by infra push (launch of IndiaAI Datasets Platform), compute access (launch of IndiaAI Compute Portal), and public innovation (DPI-backed collaborations) is helping early-stage GenAI startups in lowering go-to-market friction and accelerating B2G and B2B adoption. Indian GenAI startups face a critical resource crunch, with high compute costs and a shortage of production-ready AI talent emerging as the biggest growth barriers. While global peers enjoy deeper late-stage funding, Indian ventures often struggle to secure the patient capital needed for deep-tech R&D. This has led to an over-reliance on application-layer products built on foreign-owned models, leaving the ecosystem vulnerable to shifts in pricing and access policies. Infrastructure gaps, especially in large-scale model training and orchestration, also slow the transition from pilot projects to enterprise-grade deployments. Despite these hurdles, India holds a unique competitive edge in building domain-specific, cost-efficient AI tailored for its mobile-first, multilingual population. There is a vast untapped market for lightweight Indic-language LLMs, voice-first assistants, and AI solutions embedded into the nation's Digital Public Infrastructure like UPI and ONDC. Strategic government initiatives, including the Rs 10,372 crore IndiaAI Mission and subsidized GPU access, are creating fertile ground for startups to innovate in regulated sectors such as BFSI, healthcare, and education. By focusing on localized, high-impact applications and vertical AI specializations, Indian startups can scale rapidly and export these solutions to other emerging markets. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
